Brookstone Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,597
Closed -$189K 831
2022
Q3
$189K Buy
14,597
+1,331
+10% +$18.3K ﹤0.01% 750
2022
Q2
$192K Buy
13,266
+1,542
+13% +$25.3K ﹤0.01% 733
2022
Q1
$225K Buy
11,724
+327
+3% +$5.84K ﹤0.01% 705
2021
Q4
$199K Buy
+11,397
New +$194K ﹤0.01% 719

Other funds holding INVA

Brookstone Capital Management's INVA Position: Q4 2022 in Review

Brookstone Capital Management sold out of Innoviva (INVA) in Q4 2022, closing a stake of 14,597 shares — an estimated $189K sold.

Brookstone Capital Management first reported a position in INVA in Q4 2021 and held it in 4 quarters. The position peaked at $225K in Q1 2022. 209 funds tracked by Wall St. Rank hold INVA as of Q4 2022.

  • Brookstone Capital Management reported no remaining Innoviva position as of Q4 2022 after selling out during the quarter.
  • Brookstone Capital Management sold 14,597 Innoviva shares in Q4 2022, an estimated $189K.
  • Brookstone Capital Management first reported a position in Innoviva in Q4 2021 and held it in 4 quarters.
  • Brookstone Capital Management's Innoviva position peaked at $225K in Q1 2022.
  • 209 funds tracked by Wall St. Rank held Innoviva as of Q4 2022.

Based on Brookstone Capital Management's 13F filing for Q4 2022, filed 9 Jan 2023.